HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Betsi Kose Selected Research

Therapeutics

3/2015Roscovitine-treated HeLa cells finalize autophagy later than apoptosis by downregulating Bcl‑2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Betsi Kose Research Topics

Disease

1COVID-19
01/2021
1Neoplasms (Cancer)
03/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2015
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2015

Drug/Important Bio-Agent (IBA)

1Viral RNAIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
03/2015
1RoscovitineIBA
03/2015
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
03/2015

Therapy/Procedure

1Therapeutics
03/2015